Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TGF-β: A novel predictor and target for anti-PD-1/PD-L1 therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

The present and future of bispecific antibodies for cancer therapy
Christian Klein, Ulrich Brinkmann, Janice M. Reichert, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 4, pp. 301-319
Closed Access | Times Cited: 114
Recent advances in targeted strategies for triple-negative breast cancer
Shuangli Zhu, Yuze Wu, Bin Song, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 103
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 78
Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy
Mengke Niu, Ming Yi, Yuze Wu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 45
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 43
TGF-β signaling: critical nexus of fibrogenesis and cancer
Anna O. Giarratana, Conor M. Prendergast, Mary Salvatore, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 18
PCSK9 Inhibitors in Cancer Patients Treated with Immune-Checkpoint Inhibitors to Reduce Cardiovascular Events: New Frontiers in Cardioncology
Vincenzo Quagliariello, Irma Bisceglia, Massimiliano Berretta, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1397-1397
Open Access | Times Cited: 25
The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling
Tianye Li, Mengke Niu, Jianwei Zhou, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Mapping the landscape of histomorphological cancer phenotypes using self-supervised learning on unannotated pathology slides
Adalberto Claudio Quiros, Nicolas Coudray, Anna Yeaton, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens
Nityanand Srivastava, Salman Sadullah Usmani, Rajasekaran Subbarayan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 21
Bispecific antibody targeting TGF-β and PD-L1 for synergistic cancer immunotherapy
Tianye Li, Xinrun Wang, Mengke Niu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Crosstalk of pyroptosis and cytokine in the tumor microenvironment: from mechanisms to clinical implication
Hua Wang, Tao Wang, Shuxiang Yan, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Therapeutic targeting of TGF‐β in lung cancer
Sajjad Aftabi, Amir Barzegar Behrooz, Marco Cordani, et al.
FEBS Journal (2024)
Open Access | Times Cited: 6
MicroRNA‐431‐5p inhibits angiogenesis, lymphangiogenesis, and lymph node metastasis by affecting TGF‐β1/SMAD2/3 signaling via ZEB1 in gastric cancer
Pengpeng Liu, Pingan Ding, Jiaxuan Yang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 7, pp. 1378-1391
Closed Access | Times Cited: 4
Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response
Yuxuan Xiao, Ziyu Wang, Meng Gu, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma
Cong Luo, Xiaoyun Min, Danying Zhang
Frontiers in Immunology (2025) Vol. 15
Open Access
Targeting TGFβ and Over-Expressing GM-CSF in the Tumor with Oncolytic Adenovirus Inhibits Tumor Growth/Metastases and Augments Immune Checkpoint Inhibitor Response in a Triple Negative Breast Cancer Mouse Model
Nguyễn Thị Thanh Nhàn, Soon Cheon Shin, Beniamin Filimon, et al.
Deleted Journal (2025) Vol. 33, Iss. 1, pp. 200936-200936
Open Access
Structural Insights and Development of Small Molecule Inhibitors Targeting TGF-β Receptor I: A Comprehensive Review of Clinical Advances
Carlota Leonardo-Sousa, Rodrigo Barriga, Helena F. Florindo, et al.
Deleted Journal (2025) Vol. 33, Iss. 1, pp. 200945-200945
Open Access
Identification of Molecular Subtypes and Prognostic Features of Breast Cancer Based on TGF-β Signaling-related Genes
Jia Qu, Mei‐Huan Wang, Yue-Hua Gao, et al.
Cancer Informatics (2025) Vol. 24
Open Access
Learning single-cell spatial context through integrated spatial multiomics with CORAL
Siyu He, Matthew F Bieniosek, Dongyuan Song, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The Role of Epithelial–Mesenchymal Transition in Osteosarcoma Progression: From Biology to Therapy
Adriana Pătrașcu, Elena Ţarcă, Ludmila Lozneanu, et al.
Diagnostics (2025) Vol. 15, Iss. 5, pp. 644-644
Open Access
Stromal Fibrin Shapes Immune Infiltration Landscape of Pancreatic Ductal Adenocarcinoma
Mazharul Karim, Md. Mahedi Hasan, Seung Hyun Kim, et al.
Biomaterials (2025), pp. 123280-123280
Closed Access
Mechanisms and biomarkers of immune-related adverse events in gastric cancer
Pingan Ding, Pengpeng Liu, Lingjiao Meng, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 10
Knowledge mapping of immunotherapy in cervical carcinoma: a bibliometric analysis (2000-2023)
Ling Song, Xinmei Liang, Min Zhu, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 3
From immune checkpoints to therapies: understanding immune checkpoint regulation and the influence of natural products and traditional medicine on immune checkpoint and immunotherapy in lung cancer
Yibin Zhou, Fenglan Wang, Guangda Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top